Last quarter (Q1 2024), Edesa Biotech's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Edesa Biotech's net income was $-1.68M. See Edesa Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Total Revenue	-	-	-	-	$ 328.80K	$ 410.87K
Cost of Revenue	-	-	-	-	$ 17.60K	$ 101.29K
Gross Profit	-	-	-	-	$ 311.20K	$ 309.58K
Operating Expense	$ 8.70M	$ 9.22M	$ 18.37M	$ 13.34M	$ 6.71M	$ 3.14M
Operating Income	$ -8.70M	$ -9.22M	$ -18.37M	$ -23.68M	$ -6.40M	$ -2.83M
Net Non Operating Interest Income Expense	$ 301.38K	$ 289.85K	$ 63.52K	$ 11.16K	$ 37.78K	$ 56.84K
Other Income Expense	$ -701.87K	$ -581.04K	$ -780.26K	$ -10.34M	$ -366.00	$ -1.44K
Pretax Income	$ -7.72M	$ -8.37M	$ -17.55M	$ -13.34M	$ -6.36M	$ -2.78M
Tax Provision	$ -800.00	$ 800.00	$ 800.00	$ -800.00	$ 800.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -7.72M	$ -8.37M	$ -17.55M	$ -13.34M	$ -6.36M	$ -2.78M
Basic EPS	$ -0.72	$ -2.93	$ -1.05	$ -1.10	$ -0.74	$ -0.55
Diluted EPS	$ -0.72	$ -2.93	$ -1.05	$ -1.10	$ -0.74	$ -0.55
Basic Average Shares	$ -3.82M	$ 2.86M	$ 16.66M	$ 12.08M	$ 8.61M	$ 5.04M
Diluted Average Shares	$ -3.82M	$ 2.86M	$ 16.66M	$ 12.08M	$ 8.61M	$ 5.04M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 6.84M	-	$ 18.37M	$ -13.34M	$ -6.73M	$ 3.24M
Net Income From Continuing And Discontinued Operation	$ -7.72M	$ -8.37M	$ -17.55M	$ -13.34M	$ -6.36M	$ -2.78M
Normalized Income	$ -6.72M	$ -6.15M	$ -12.90M	$ -13.34M	$ -4.68M	$ -2.78M
Interest Expense	-	-	-	-	-	-
EBIT	$ -7.72M	$ -8.37M	$ -17.55M	$ -13.34M	$ -6.36M	$ -2.83M
EBITDA	$ -7.52M	$ -8.19M	$ -17.43M	$ -13.22M	$ -6.31M	$ -2.83M

Currency in USD

Edesa Biotech Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing